PFBT
TVTX icon

Parkside Financial Bank & Trust’s Travere Therapeutics TVTX Stock Holding History

Parkside Financial Bank & Trust’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.09K Buy
72
+1
+1% +$44 ﹤0.01% 1958
2026
Q1 		$2.11K Hold
71
– – ﹤0.01% 2098
2025
Q4 		$2.71K Hold
71
– – ﹤0.01% 1995
2025
Q3 		$1.7K Hold
71
– – ﹤0.01% 2085
2025
Q2 		$1.05K Buy
71
+11
+18% +$182 ﹤0.01% 2249
2025
Q1 		$1.08K Buy
+60
New +$1.22K ﹤0.01% 2078

Other funds holding TVTX

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Parkside Financial Bank & Trust's TVTX Position: Q2 2026 in Review

Parkside Financial Bank & Trust increased its Travere Therapeutics (TVTX) stake by 1.4% in Q2 2026, buying an estimated $44 and bringing the position to 72 shares worth $4.09K. The position accounts for ﹤0.01% of the portfolio, ranked #1958.

Parkside Financial Bank & Trust first reported a position in TVTX in Q1 2025 and has held it in 6 quarters since. 320 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.

  • Parkside Financial Bank & Trust held 72 shares of Travere Therapeutics worth $4.09K as of Q2 2026.
  • Parkside Financial Bank & Trust bought 1 Travere Therapeutics share in Q2 2026, an estimated $44.
  • Travere Therapeutics made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #1958 holding.
  • Parkside Financial Bank & Trust first reported a position in Travere Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 320 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.